Zhou Yongfeng, Wang Junnan, Zhang Dingkun, Liu Jiaxin, Wu Qinghua, Chen Jiang, Tan Peng, Xing Boyu, Han Yanzhong, Zhang Ping, Xiao Xiaohe, Pei Jin
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, 611137, Sichuan, China.
Department of Pharmacy, Medical Supplies Center of PLA General Hospital, 100#, West 4th Ring Middle Rd., Fengtai, Beijing, 10039, China.
Chin Med. 2021 Dec 11;16(1):135. doi: 10.1186/s13020-021-00543-x.
Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR) and a serious threat to health that affects disease treatments. At present, no targeted clinical drugs are available for DILI. Traditional natural medicines have been widely used as health products. Some natural medicines exert specific hepatoprotective effects, with few side effects and significant clinical efficacy. Thus, natural medicines may be a promising direction for DILI treatment. In this review, we summarize the current knowledge, common drugs and mechanisms of DILI, as well as the clinical trials of natural drugs and their bioactive components in anticipation of the future development of potential hepatoprotective drugs.
药物性肝损伤(DILI)是一种常见的药物不良反应(ADR),对影响疾病治疗的健康构成严重威胁。目前,尚无针对DILI的临床靶向药物。传统天然药物已被广泛用作保健品。一些天然药物具有特定的肝脏保护作用,副作用少且临床疗效显著。因此,天然药物可能是DILI治疗的一个有前景的方向。在本综述中,我们总结了DILI的现有知识、常见药物和机制,以及天然药物及其生物活性成分的临床试验,以期潜在肝脏保护药物的未来发展。